All Relations between Alzheimer Disease and hippocampus

Publication Sentence Publish Date Extraction Date Species
Letten F Saugsta. Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3? Nutrition and health. vol 18. issue 2. 2006-09-07. PMID:16859172. this review describes signs of n-3 deficit in alzheimer and parkinson disease, where maximum change involves the primary sites: olfactory cortex and the hippocampus. 2006-09-07 2023-08-12 Not clear
Y Li, J Li, S Segal, J Wegiel, S De Santi, J Zhan, M J de Leo. Hippocampal cerebrospinal fluid spaces on MR imaging: Relationship to aging and Alzheimer disease. AJNR. American journal of neuroradiology. vol 27. issue 4. 2006-08-30. PMID:16611790. hippocampal cerebrospinal fluid spaces on mr imaging: relationship to aging and alzheimer disease. 2006-08-30 2023-08-12 Not clear
Y Li, J Li, S Segal, J Wegiel, S De Santi, J Zhan, M J de Leo. Hippocampal cerebrospinal fluid spaces on MR imaging: Relationship to aging and Alzheimer disease. AJNR. American journal of neuroradiology. vol 27. issue 4. 2006-08-30. PMID:16611790. perihippocampal fissures (phfs) and hippocampal sulcus residual cavities (hscs) are common findings in the mr imaging examination of the hippocampus in aging and alzheimer disease (ad); however, little is known about how to distinguish them or their relative clinical relevance. 2006-08-30 2023-08-12 Not clear
Zhuo Zhang, Ting-Hua Wang, Yu-Hong Zhu, Zhong-Tang Feng, Bing Sun, Yan-li H. [Distribution and change of NGF, BDNF and NT3 in the hippocampus of rat with AD]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition. vol 36. issue 6. 2006-08-29. PMID:16334554. to investigate the distribution and change of ngf, bdnf and nt3 in hippocampus of rat with alzheimer disease(ad) by immunohistochemistry. 2006-08-29 2023-08-12 rat
Jianmin Wu, Xizeng Mao, Tao Cai, Jingchu Luo, Liping We. KOBAS server: a web-based platform for automated annotation and pathway identification. Nucleic acids research. vol 34. issue Web Server issue. 2006-08-29. PMID:16845106. we demonstrate the usability of the server by finding statistically enriched pathways in a set of upregulated genes in alzheimer's disease (ad) hippocampal cornu ammonis 1 (ca1). 2006-08-29 2023-08-12 Not clear
Travis R Stoub, Leyla deToledo-Morrell, Glenn T Stebbins, Sue Leurgans, David A Bennett, Raj C Sha. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. vol 103. issue 26. 2006-08-23. PMID:16785436. hippocampal disconnection contributes to memory dysfunction in individuals at risk for alzheimer's disease. 2006-08-23 2023-08-12 human
Liang Wang, Yufeng Zang, Yong He, Meng Liang, Xinqing Zhang, Lixia Tian, Tao Wu, Tianzi Jiang, Kuncheng L. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. NeuroImage. vol 31. issue 2. 2006-08-14. PMID:16473024. changes in hippocampal connectivity in the early stages of alzheimer's disease: evidence from resting state fmri. 2006-08-14 2023-08-12 Not clear
Liang Wang, Yufeng Zang, Yong He, Meng Liang, Xinqing Zhang, Lixia Tian, Tao Wu, Tianzi Jiang, Kuncheng L. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. NeuroImage. vol 31. issue 2. 2006-08-14. PMID:16473024. a selective distribution of alzheimer's disease (ad) pathological lesions in specific cortical layers isolates the hippocampus from the rest of the brain. 2006-08-14 2023-08-12 Not clear
J R Walto. Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology. vol 27. issue 3. 2006-08-10. PMID:16458972. aluminum in hippocampal neurons from humans with alzheimer's disease. 2006-08-10 2023-08-12 human
J R Walto. Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology. vol 27. issue 3. 2006-08-10. PMID:16458972. using a staining technique developed in 2004, we examined hippocampal tissue from autopsy-confirmed cases of alzheimer's disease (ad) and controls. 2006-08-10 2023-08-12 human
Michael Basso, John Yang, Lauren Warren, Martha G MacAvoy, Pradeep Varma, Richard A Bronen, Christopher H van Dyc. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry research. vol 146. issue 3. 2006-08-10. PMID:16524704. volumetry of amygdala and hippocampus and memory performance in alzheimer's disease. 2006-08-10 2023-08-12 human
Michael Basso, John Yang, Lauren Warren, Martha G MacAvoy, Pradeep Varma, Richard A Bronen, Christopher H van Dyc. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry research. vol 146. issue 3. 2006-08-10. PMID:16524704. within the ad group, performance on the memory-orientation subscale of the alzheimer's disease assessment scale-cognition (adas-cog) was significantly correlated with normalized amygdaloid volume but not with normalized hippocampal volume. 2006-08-10 2023-08-12 human
Pamela Rizk, Julio Salazar, Rita Raisman-Vozari, Marc Marien, Merle Ruberg, Francis Colpaert, Thomas Debei. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 6. 2006-08-07. PMID:16292321. by promoting the survival of new endogenously formed neurons, dexefaroxan treatment represents a potential therapeutic strategy for maintaining adult neurogenesis in neurodegenerative conditions, such as alzheimer's disease, that affect the hippocampus. 2006-08-07 2023-08-12 rat
Geneviève Evin, Marijke Fleur Sernee, Colin L Master. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies. CNS drugs. vol 20. issue 5. 2006-08-04. PMID:16696577. this protein fragment abnormally accumulates in the brain cortex and hippocampus of patients with alzheimer's disease, and self-aggregates to form toxic oligomers causing neurodegeneration.abeta is heterogeneous and produced from a precursor protein (amyloid precursor protein [app]) by two sequential proteolytic cleavages that involve beta- and gamma-secretases. 2006-08-04 2023-08-12 Not clear
Yong-Jie Zhang, Ya-Fei Xu, Ying-Hua Liu, Jun Yin, Hong-Lian Li, Qun Wang, Jian-Zhi Wan. Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 20. issue 9. 2006-07-31. PMID:16816118. to investigate the upstream effector that led to tau hyperphosphorylation, nitration, and accumulation as seen in alzheimer's disease brain, and the underlying mechanisms, we bilaterally injected sin-1, a recognized peroxynitrite donor, into the hippocampus of rat brain. 2006-07-31 2023-08-12 rat
Rukhsana Sultana, Debra Boyd-Kimball, H Fai Poon, Jain Cai, William M Pierce, Jon B Klein, William R Markesbery, Xiao Zhen Zhou, Kun Ping Lu, D Allan Butterfiel. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiology of aging. vol 27. issue 7. 2006-07-27. PMID:15950321. oxidative modification and down-regulation of pin1 in alzheimer's disease hippocampus: a redox proteomics analysis. 2006-07-27 2023-08-12 Not clear
G Page, A Rioux Bilan, S Ingrand, C Lafay-Chebassier, S Pain, M C Perault Pochat, C Bouras, T Bayer, J Hugo. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience. vol 139. issue 4. 2006-07-26. PMID:16581193. we have shown previously that phosphorylated double-stranded rna-dependent protein kinase is present in degenerating hippocampal neurons and in senile plaques of alzheimer's disease brains and that genetically down-regulating double-stranded rna-dependent protein kinase activity protects against in vitro beta-amyloid peptide neurotoxicity. 2006-07-26 2023-08-12 mouse
Chigusa Uotani, Kaoru Sugimori, Katsuji Kobayash. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease. Psychiatry and clinical neurosciences. vol 60. issue 3. 2006-07-26. PMID:16732748. association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of alzheimer's disease. 2006-07-26 2023-08-12 Not clear
Chigusa Uotani, Kaoru Sugimori, Katsuji Kobayash. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease. Psychiatry and clinical neurosciences. vol 60. issue 3. 2006-07-26. PMID:16732748. a 3-d volumetric study of the medial temporal lobe (mtl) was performed to evaluate how a minimum thickness of the mtl (mtmtl), a visually estimated measure, is associated with other mtl measures, maximal and minimal hippocampal length (max-hl, min-hl) and hippocampal volume, all measured with a 3-d device, neurolucida, in 33 patients with alzheimer's disease (ad), seven patients with mild cognitive impairment (mci), and 20 age-matched controls. 2006-07-26 2023-08-12 Not clear
Vanessa Gil, Oriol Nicolas, Ana Mingorance, Jesús Mariano Ureña, Bor Lueng Tang, Tatsumi Hirata, Javier Sáez-Valero, Isidro Ferrer, Eduardo Soriano, José Antonio del Rí. Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease. Journal of neuropathology and experimental neurology. vol 65. issue 5. 2006-07-26. PMID:16772867. nogo-a expression in the human hippocampus in normal aging and in alzheimer disease. 2006-07-26 2023-08-12 human